Artigos de revistas sobre o tema "Muscle-Specific Kinase (MuSK)"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 50 melhores artigos de revistas para estudos sobre o assunto "Muscle-Specific Kinase (MuSK)".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
Bromann, P. A., H. Zhou e J. R. Sanes. "Kinase- and rapsyn-independent activities of the muscle-specific kinase (MuSK)". Neuroscience 125, n.º 2 (janeiro de 2004): 417–26. http://dx.doi.org/10.1016/j.neuroscience.2003.12.031.
Texto completo da fonteMoon, So-Young, Sang-Soo Lee e Yoon-Ho Hong. "Muscle atrophy in muscle-specific tyrosine kinase (MuSK)-related myasthenia gravis". Journal of Clinical Neuroscience 18, n.º 9 (setembro de 2011): 1274–75. http://dx.doi.org/10.1016/j.jocn.2011.01.010.
Texto completo da fonteSander, Andreas, Boris A. Hesser e Veit Witzemann. "MuSK induces in vivo acetylcholine receptor clusters in a ligand-independent manner". Journal of Cell Biology 155, n.º 7 (17 de dezembro de 2001): 1287–96. http://dx.doi.org/10.1083/jcb.200105034.
Texto completo da fonteKoneczny, Inga, Judith Cossins e Angela Vincent. "The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis". Journal of Anatomy 224, n.º 1 (4 de março de 2013): 29–35. http://dx.doi.org/10.1111/joa.12034.
Texto completo da fonteFuhrer, C. "Association of muscle-specific kinase MuSK with the acetylcholine receptor in mammalian muscle". EMBO Journal 16, n.º 16 (15 de agosto de 1997): 4951–60. http://dx.doi.org/10.1093/emboj/16.16.4951.
Texto completo da fonteStrochlic, Laure, Annie Cartaud e Jean Cartaud. "The synaptic muscle-specific kinase (MuSK) complex: New partners, new functions". BioEssays 27, n.º 11 (2005): 1129–35. http://dx.doi.org/10.1002/bies.20305.
Texto completo da fonteAli, Hassam, Rahul Pamarthy, Nayab Ahsan, WashmaAwan e Shiza Sarfraz. "Muscle-Specific Tyrosine Kinase-Associated Myasthenia Gravis: A Neuromuscular Surprise". Case Reports in Neurological Medicine 2021 (28 de dezembro de 2021): 1–3. http://dx.doi.org/10.1155/2021/1326442.
Texto completo da fonteOh, Jeeyoung, Woo Ick Yang, Jeong Hoon Cho e Il Nam Sunwoo. "Muscle-specific receptor tyrosine kinase (MuSK) myasthenia gravis associated with castleman disease". Annals of Clinical Neurophysiology 19, n.º 1 (2017): 74. http://dx.doi.org/10.14253/acn.2017.19.1.74.
Texto completo da fonteAtassi, Nazem, e Anthony A. Amato. "Muscle-specific kinase (MuSK) antibody-associated myasthenia gravis after bone marrow transplantation". Muscle & Nerve 38, n.º 2 (agosto de 2008): 1074–75. http://dx.doi.org/10.1002/mus.21023.
Texto completo da fonteBenrhouma, Hanene, Hedia Klaa, Rania Ben Aoun, Aida Rouissi, Melika Ben Ahmed, Ichraf Kraoua, Ilhem Ben Youssef-Turki e Thouraya Ben Younes. "Muscle-Specific Kinase Autoimmune Myasthenia Gravis: Report of a Pediatric Case and Literature Review". Neuropediatrics 50, n.º 02 (21 de dezembro de 2018): 116–21. http://dx.doi.org/10.1055/s-0038-1676514.
Texto completo da fonteBhaskar, Shalini, e Mohammed Fauzi Bin Abdul Rani. "MuSK-Myasthenia Gravis Unmasked by Hydroxychloroquine". Case Reports in Medicine 2022 (15 de julho de 2022): 1–4. http://dx.doi.org/10.1155/2022/4802538.
Texto completo da fonteHuijbers, Maartje G., Dana L. Vergoossen, Yvonne E. Fillié-Grijpma, Inge E. van Es, Marvyn T. Koning, Linda M. Slot, Hendrik Veelken, Jaap J. Plomp, Silvère M. van der Maarel e Jan J. Verschuuren. "MuSK myasthenia gravis monoclonal antibodies". Neurology - Neuroimmunology Neuroinflammation 6, n.º 3 (21 de fevereiro de 2019): e547. http://dx.doi.org/10.1212/nxi.0000000000000547.
Texto completo da fontePál, Zsuzsanna, Judit Boczán, Benjamin Bereznai, Gábor Lovas e Mária Judit Molnár. "Treatment of anti-MuSK antibody positive myasthenia gravis". Orvosi Hetilap 152, n.º 39 (setembro de 2011): 1586–89. http://dx.doi.org/10.1556/oh.2011.29177.
Texto completo da fonteGhazanfari, Nazanin, Marco Morsch, Stephen W. Reddel, Simon X. Liang e William D. Phillips. "Muscle-specific kinase (MuSK) autoantibodies suppress the MuSK pathway and ACh receptor retention at the mouse neuromuscular junction". Journal of Physiology 592, n.º 13 (1 de julho de 2014): 2881–97. http://dx.doi.org/10.1113/jphysiol.2013.270207.
Texto completo da fonteJones, Nina, W. Rod Hardy, Matthew B. Friese, Claus Jorgensen, Matthew J. Smith, Neil M. Woody, Steven J. Burden e Tony Pawson. "Analysis of a Shc Family Adaptor Protein, ShcD/Shc4, That Associates with Muscle-Specific Kinase". Molecular and Cellular Biology 27, n.º 13 (23 de abril de 2007): 4759–73. http://dx.doi.org/10.1128/mcb.00184-07.
Texto completo da fonteElliott, Jeffrey. "A novel MUSK mutation in a patient with CMS9". RRNMF Neuromuscular Journal 4, n.º 2 (19 de junho de 2023): 10–15. http://dx.doi.org/10.17161/rrnmf.v4i2.18588.
Texto completo da fonteCartaud, Annie, Laure Strochlic, Manuel Guerra, Benoît Blanchard, Monique Lambergeon, Eric Krejci, Jean Cartaud e Claire Legay. "MuSK is required for anchoring acetylcholinesterase at the neuromuscular junction". Journal of Cell Biology 165, n.º 4 (24 de maio de 2004): 505–15. http://dx.doi.org/10.1083/jcb.200307164.
Texto completo da fonteMagnussen, Marcus, Ioannis Karakis e Taylor B. Harrison. "The Myotonic Plot Thickens: Electrical Myotonia in Antimuscle-Specific Kinase Myasthenia Gravis". Case Reports in Neurological Medicine 2015 (2015): 1–4. http://dx.doi.org/10.1155/2015/242691.
Texto completo da fonteFeng, Zhihua, Steven Lam, Elena-Marie Sandino Tenn, Arundhati Sengupta Ghosh, Sarah Cantor, Wei Zhang, Pei-Fen Yen et al. "Activation of Muscle-Specific Kinase (MuSK) Reduces Neuromuscular Defects in the Delta7 Mouse Model of Spinal Muscular Atrophy (SMA)". International Journal of Molecular Sciences 22, n.º 15 (27 de julho de 2021): 8015. http://dx.doi.org/10.3390/ijms22158015.
Texto completo da fonteMurray, Earnest L., Sachin Kedar e V. V. Vedanarayanan. "Transmission of Maternal Muscle-Specific Tyrosine Kinase (MuSK) to Offspring: Report of Two Cases". Journal of Clinical Neuromuscular Disease 12, n.º 2 (dezembro de 2010): 76–79. http://dx.doi.org/10.1097/cnd.0b013e3181f8a9aa.
Texto completo da fonteThurtell, Matthew J., Jayamala Parmar, Garth A. Nicholson e Stephen W. Reddel. "404: MuSK (muscle specific tyrosine kinase) seropositive and seronegative autoimmune myasthenia gravis in Australasia". Journal of Clinical Neuroscience 14, n.º 10 (outubro de 2007): 1015. http://dx.doi.org/10.1016/j.jocn.2007.02.027.
Texto completo da fonteFink, H., M. Blobner e J. A. J. Martyn. "Differential Up-Regulation of Muscle Specific Kinase (MuSK) Distant and Local to Burn Site". Journal of Burn Care & Rehabilitation 23 (março de 2002): S123. http://dx.doi.org/10.1097/00004630-200203002-00162.
Texto completo da fonteZhou, Lan, John McConville, Vinay Chaudhry, Robert N. Adams, Richard L. Skolasky, Angela Vincent e Daniel B. Drachman. "Clinical comparison of muscle-specific tyrosine kinase (MuSK) antibody-positive and -negative myasthenic patients". Muscle & Nerve 30, n.º 1 (2004): 55–60. http://dx.doi.org/10.1002/mus.20069.
Texto completo da fonteDziadkowiak, Edyta, Dagmara Baczyńska e Marta Waliszewska-Prosół. "MuSK Myasthenia Gravis—Potential Pathomechanisms and Treatment Directed against Specific Targets". Cells 13, n.º 6 (21 de março de 2024): 556. http://dx.doi.org/10.3390/cells13060556.
Texto completo da fonteZhou, Heather, David J. Glass, George D. Yancopoulos e Joshua R. Sanes. "Distinct Domains of Musk Mediate Its Abilities to Induce and to Associate with Postsynaptic Specializations". Journal of Cell Biology 146, n.º 5 (6 de setembro de 1999): 1133–46. http://dx.doi.org/10.1083/jcb.146.5.1133.
Texto completo da fonteMcConville, J., W. Hoch, J. Newsom-Davies, D. Beeson e A. Vincent. "Autoantibodies to the Muscle Specific Kinase, MuSK in Myasthenia Gravis seronegative for Acetylcholine Receptor Antibodies". Clinical Science 103, s47 (1 de julho de 2002): 68P. http://dx.doi.org/10.1042/cs103068p.
Texto completo da fonteLanfranconi, S., S. Corti, P. Baron, G. Conti, L. Borellini, N. Bresolin e A. Bersano. "Anti-MuSK-Positive Myasthenia Gravis in a Patient with Parkinsonism and Cognitive Impairment". Neurology Research International 2011 (2011): 1–4. http://dx.doi.org/10.1155/2011/859802.
Texto completo da fonteCao, Michelangelo, Wei-Wei Liu, Susan Maxwell, Saif Huda, Richard Webster, Amelia Evoli, David Beeson, Judith A. Cossins e Angela Vincent. "IgG1-3 MuSK Antibodies Inhibit AChR Cluster Formation, Restored by SHP2 Inhibitor, Despite Normal MuSK, DOK7, or AChR Subunit Phosphorylation". Neurology - Neuroimmunology Neuroinflammation 10, n.º 6 (15 de agosto de 2023): e200147. http://dx.doi.org/10.1212/nxi.0000000000200147.
Texto completo da fonteChen, Yanxun, Maohao Guan, Fengqiang Yu, Zhongshan Yang, Weiqiang Yi, Xuan Huang, Ruiqin Qiu e Fancai Lai. "Protein Tyrosine Phosphatase Receptor Type R (PTPRR) Reduces AChR Clustering by Dephosphorylating MuSK". Disease Markers 2022 (5 de setembro de 2022): 1–10. http://dx.doi.org/10.1155/2022/5160624.
Texto completo da fonteVergoossen, Dana L. E., Jaap J. Plomp, Christoph Gstöttner, Yvonne E. Fillié-Grijpma, Roy Augustinus, Robyn Verpalen, Manfred Wuhrer et al. "Functional monovalency amplifies the pathogenicity of anti-MuSK IgG4 in myasthenia gravis". Proceedings of the National Academy of Sciences 118, n.º 13 (22 de março de 2021): e2020635118. http://dx.doi.org/10.1073/pnas.2020635118.
Texto completo da fonteGlass, D. J., E. D. Apel, S. Shah, D. C. Bowen, T. M. DeChiara, T. N. Stitt, J. R. Sanes e G. D. Yancopoulos. "Kinase domain of the muscle-specific receptor tyrosine kinase (MuSK) is sufficient for phosphorylation but not clustering of acetylcholine receptors: Required role for the MuSK ectodomain?" Proceedings of the National Academy of Sciences 94, n.º 16 (5 de agosto de 1997): 8848–53. http://dx.doi.org/10.1073/pnas.94.16.8848.
Texto completo da fonteLu, Zhonghua, Hyun-Soo Je, Paul Young, Jimmy Gross, Bai Lu e Guoping Feng. "Regulation of synaptic growth and maturation by a synapse-associated E3 ubiquitin ligase at the neuromuscular junction". Journal of Cell Biology 177, n.º 6 (18 de junho de 2007): 1077–89. http://dx.doi.org/10.1083/jcb.200610060.
Texto completo da fonteHuda, Saif, Michelangelo Cao, Anna De Rosa, Mark Woodhall, Pedro M. Rodriguez Cruz, Judith Cossins, Michelangelo Maestri et al. "SHP2 inhibitor protects AChRs from effects of myasthenia gravis MuSK antibody". Neurology - Neuroimmunology Neuroinflammation 7, n.º 1 (12 de dezembro de 2019): e645. http://dx.doi.org/10.1212/nxi.0000000000000645.
Texto completo da fonteYu, Zheng, Meiying Zhang, Hongyang Jing, Peng Chen, Rangjuan Cao, Jinxiu Pan, Bin Luo et al. "Characterization of LRP4/Agrin Antibodies From a Patient With Myasthenia Gravis". Neurology 97, n.º 10 (7 de julho de 2021): e975-e987. http://dx.doi.org/10.1212/wnl.0000000000012463.
Texto completo da fonteBromann, Paul A., Joshua A. Weiner, Elizabeth D. Apel, Renate M. Lewis e Joshua R. Sanes. "A putative ariadne-like E3 ubiquitin ligase (PAUL) that interacts with the muscle-specific kinase (MuSK)". Gene Expression Patterns 4, n.º 1 (janeiro de 2004): 77–84. http://dx.doi.org/10.1016/s1567-133x(03)00146-7.
Texto completo da fonteBasile, Umberto, Cecilia Napodano, Francesca Gulli, Krizia Pocino, Riccardo Di Santo, Laura Todi, Valerio Basile, Carlo Provenzano, Gabriele Ciasca e Mariapaola Marino. "Laboratory Investigation of Hybrid IgG4 k/λ in MuSK Positive Myasthenia Gravis". International Journal of Molecular Sciences 22, n.º 17 (24 de agosto de 2021): 9142. http://dx.doi.org/10.3390/ijms22179142.
Texto completo da fonteTrakas, Nikolaos, Paraskevi Zisimopoulou e Socrates J. Tzartos. "Development of a highly sensitive diagnostic assay for muscle-specific tyrosine kinase (MuSK) autoantibodies in myasthenia gravis". Journal of Neuroimmunology 240-241 (dezembro de 2011): 79–86. http://dx.doi.org/10.1016/j.jneuroim.2011.09.007.
Texto completo da fonteSanders, D. "P01.3 Esophageal adynamia in a patient with muscle specific tyrosine kinase (MuSK) antibody positive myasthenia gravis (MG)". Clinical Neurophysiology 117 (setembro de 2006): 122. http://dx.doi.org/10.1016/j.clinph.2006.06.180.
Texto completo da fonteGros, Katarina, Urška Matkovič, Giulia Parato, Katarina Miš, Elisa Luin, Annalisa Bernareggi, Marina Sciancalepore, Tomaž Marš, Paola Lorenzon e Sergej Pirkmajer. "Neuronal Agrin Promotes Proliferation of Primary Human Myoblasts in an Age-Dependent Manner". International Journal of Molecular Sciences 23, n.º 19 (4 de outubro de 2022): 11784. http://dx.doi.org/10.3390/ijms231911784.
Texto completo da fonteBeland, B., C. Hahn, K. Jamani, S. Chhibber, C. White, H. Atkins e J. Storek. "P.035 Autologous hematopoietic stem cell transplant for the treatment of refractory myasthenia gravis with anti-muscle specific kinase antibodies". Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 50, s2 (junho de 2023): S67. http://dx.doi.org/10.1017/cjn.2023.139.
Texto completo da fonteSkriapa, Lamprini, Paraskevi Zisimopoulou, Nikolaos Trakas, Eirini Grapsa e Socrates J. Tzartos. "Expression of extracellular domains of muscle specific kinase (MuSK) and use as immunoadsorbents for the development of an antigen-specific therapy". Journal of Neuroimmunology 276, n.º 1-2 (novembro de 2014): 150–58. http://dx.doi.org/10.1016/j.jneuroim.2014.09.013.
Texto completo da fonteSherpa, Michael, Ravi K. Metai, Viki Kumar, Tinu Hirachan, Kawser U. Ahmed e Sharon J. Atkinson. "Comorbid Human Immunodeficiency Virus (HIV) and Muscle-Specific Kinase (MuSK) Myasthenia Gravis: A Case Report and Literature Review". American Journal of Case Reports 18 (20 de abril de 2017): 427–30. http://dx.doi.org/10.12659/ajcr.903108.
Texto completo da fonteJha, Smita, Kaiping Xu, Takahiro Maruta, Minako Oshima, Dennis R. Mosier, M. Zouhair Atassi e Werner Hoch. "Myasthenia gravis induced in mice by immunization with the recombinant extracellular domain of rat muscle-specific kinase (MuSK)". Journal of Neuroimmunology 175, n.º 1-2 (junho de 2006): 107–17. http://dx.doi.org/10.1016/j.jneuroim.2006.03.016.
Texto completo da fonteÇetiner, Mustafa, Gönül Akdağ, Fatma Akkoyun Arikan e Sibel Canbaz Kabay. "How to manage MuSK antibody-positive myasthenic crisis during pregnancy?" Ideggyógyászati szemle 75, n.º 3-4 (2022): 141–44. http://dx.doi.org/10.18071/isz.75.0141.
Texto completo da fonteStrochlic, Laure, Annie Cartaud, Valérie Labas, Werner Hoch, Jean Rossier e Jean Cartaud. "Magi-1c". Journal of Cell Biology 153, n.º 5 (28 de maio de 2001): 1127–32. http://dx.doi.org/10.1083/jcb.153.5.1127.
Texto completo da fonteBasile, Umberto, Mariapaola Marino, Cecilia Napodano, Krizia Pocino, Paolo Emilio Alboini, Francesca Gulli, Amelia Evoli, Carlo Provenzano e Emanuela Bartoccioni. "Serological Immunoglobulin-Free Light Chain Profile in Myasthenia Gravis Patients". Journal of Immunology Research 2018 (2018): 1–8. http://dx.doi.org/10.1155/2018/9646209.
Texto completo da fonteInoue, Ken-ichi, Jun Tsugawa, Jiro Fukae, Kosuke Fukuhara, Hiroyasu Kawano, Shinsuke Fujioka e Yoshio Tsuboi. "Myasthenia Gravis with Anti-Muscle-Specific Tyrosine Kinase Antibody during Pregnancy and Risk of Neonatal Myasthenia Gravis: A Case Report and Review of the Literature". Case Reports in Neurology 12, n.º 1 (17 de março de 2020): 114–20. http://dx.doi.org/10.1159/000506189.
Texto completo da fonteÇebi, M., H. Durmuş, V. Yılmaz, S. P. Yentür, F. Aysal, P. Oflazer, Y. Parman, F. Deymeer e G. Saruhan‐Direskeneli. "Relation of HLA‐DRB1 to IgG4 autoantibody and cytokine production in muscle‐specific tyrosine kinase myasthenia gravis (MuSK‐MG)". Clinical & Experimental Immunology 197, n.º 2 (12 de abril de 2019): 214–21. http://dx.doi.org/10.1111/cei.13302.
Texto completo da fonteGhazanfari, Nazanin, Erna L. T. B. Linsao, Sofie Trajanovska, Marco Morsch, Paul Gregorevic, Simon X. Liang, Stephen W. Reddel e William D. Phillips. "Forced expression of muscle specific kinase slows postsynaptic acetylcholine receptor loss in a mouse model of MuSK myasthenia gravis". Physiological Reports 3, n.º 12 (dezembro de 2015): e12658. http://dx.doi.org/10.14814/phy2.12658.
Texto completo da fonteArman, Sam, Norman Kock, George Mochloulis e Gorande Kanabar. "Bilateral vocal fold paresis: the only presenting sign of anti-MUSK antibody myasthenia gravis". BMJ Case Reports 14, n.º 1 (janeiro de 2021): e234070. http://dx.doi.org/10.1136/bcr-2019-234070.
Texto completo da fonte